Puri Michal Nath bought NVCR
March 3, 2026 · Form 4 insider transaction
Puri Michal Nath bought 40,100 shares of NovoCure Limited at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,100
Price
$0.00
Total value
N/A
InsiderPuri Michal Nath
RoleOfficer
CompanyNovoCure Limited (NVCR)
SecurityOrdinary Shares
Transaction codeA: Grant or award
Transaction dateMarch 3, 2026
Filing dateMarch 5, 2026
Shares owned after202,422
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates.